Share
London: Vaccines tailored to tackle COVID-19 variants are to be accelerated through new state-of-the-art labs, Health Secretary Matt Hancock has announced today (Wednesday 5 May).
The government will invest £29.3 million through the Vaccines Taskforce in Public Health England’s new testing facilities at Porton Down, to assess the effectiveness of existing and new vaccines against variants of concern.
The funding will increase the site’s current capacity from 700 to 3,000 blood samples tested a week in order to fast-track variant vaccines. These tests measure the levels of antibodies to COVID-19 that are generated by the vaccines.
The investment will enable Porton Down’s expert scientists to accelerate the pace and scale of specialised testing to support the rapid development of vaccines designed to combat specific mutations of COVID-19.
UK Government funds facility to test vaccines against COVID-19 variants
SHARES
The UK Government will invest £29.3 million to test the effectiveness of COVID-19 vaccines against variants in 3,000 blood samples a week.
Vaccines developed to tackle COVID-19 variants are to be accelerated through new state-of-the-art labs, the UK Government has announced. The Government will invest £29.3 million through the Vaccines Taskforce into Public Health England’s new testing facilities at Porton Down, to assess the effectiveness of existing and new vaccines against variants of concern.
The funding will increase the site’s current capacity from 700 to 3,000 blood samples tested a week in order to fast-track variant vaccines. These tests measure the levels of antibodies to COVID-19 that are generated by the vaccines.